Overview
Yanping Ding practices practicing medicine in Beijing, China.
Their clinical expertise encompasses Triple-Negative Breast Cancer, Non-Hodgkin Lymphoma, Lymphofollicular Hyperplasia, and Neurotoxicity Syndromes.
They are actively involved in clinical research, co-authoring 41 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yanping Ding
Is Yanping Ding a top-rated expert for Triple-Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Yanping Ding is classified as an Experienced expert for Triple-Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yanping Ding participate in research or clinical trials?
Yes. Yanping Ding has published 41 articles and abstracts on conditions like Triple-Negative Breast Cancer. You can view a list of Yanping Ding's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lymphofollicular Hyperplasia
- Neurotoxicity SyndromesDing isExperienced. Learn about Neurotoxicity Syndromes.
- Non-Hodgkin LymphomaDing isExperienced. Learn about Non-Hodgkin Lymphoma.
- Triple-Negative Breast Cancer